Clinical Study
The Validation of a New Visual Anaemia Evaluation Tool HemoHue HH1 in Patients with End-Stage Renal Disease
Table 2
Test specificities in detecting binary outcomes.
| Outcome | Sens. | Spec. | PPV | NPV | Kappa | Sens. | Spec. | PPV | NPV | Kappa |
| | 1st session | 2nd session |
| Hb < 10 g/dL | 50 | 73 | 29 | 89 | 0.34 | 33 | 92 | 38 | 91 | 0.29 | 10 g/dl ≤ Hb ≤ 12 g/dL | 53 | 48 | 60 | 42 | 0.22 | 74 | 56 | 70 | 62 | 0.31 | Hb > 12 g/dL | 39 | 91 | 58 | 82 | 0.45 | 65 | 87 | 71 | 83 | 0.46 |
| | Physicians | Non-physicians |
| Hb < 10 g/dL | 32 | 87 | 29 | 88 | 0.44 | 55 | 76 | 29 | 90 | 0.39 | 10 g/dL ≤ Hb ≤ 12 g/dL | 64 | 51 | 64 | 51 | −0.01 | 59 | 46 | 60 | 45 | −0.04 | Hb > 12 g/dL | 63 | 86 | 63 | 86 | 0.58 | 35 | 89 | 54 | 79 | 0.41 |
|
|
Sensitivity, specificity, and positive and negative predictive values are given in percents.
|